Aarti Drugs Ltd - 524348 - Shareholding for the Period Ended June 30, 2019
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here20-07-2019
20-07-2019
Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Consider, Approve And Take On Record Audited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2019.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2019 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2019.17-07-2019
AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2019 received from Link Intime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company.17-07-2019
AARTI DRUGS LTD. - 524348 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 2240 Name of the Signatory :- Rushikesh DeoleDesignation :- Company Secretary and Compliance Officer17-07-2019
AARTI DRUGS LTD. - 524348 - Fixes Book Closure for Final Dividend & AGM
Aarti Drugs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 30, 2019 to August 06, 2019 (both days inclusive) for the purpose of Payment of Final Dividend & 34th Annual General Meeting (AGM) of the Company to be held on August 06, 2019.12-07-2019
AARTI DRUGS LTD. - 524348 - Compliance Of Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of Listing Regulations, the Register of Members and Share Transfer Books of the Company will remain closed for the purpose of payment of Dividend, if approved at AGM, from Tuesday, July 30, 2019 to Tuesday, August 6, 2019 (both days inclusive).11-07-2019
AARTI DRUGS LTD. - 524348 - Reg. 34 (1) Annual Report
Annual Report for the Financial Year 2018-19 along with the Notice of 34th Annual General Meeting (AGM)11-07-2019
Aarti Drugs Ltd - 524348 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aashyav Business Trust10-07-2019
Aarti Drugs Ltd - 524348 - Closure of Trading Window
This is to inform you that the Trading Window for trading in Equity Shares of the Company will remain closed from Monday, July 1, 2019 till the expiry of 48 hours after the declaration of financial results of the Company for the quarter ended June 30, 2019.28-06-2019
Aarti Drugs Ltd - 524348 - Compliance Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
In compliance with Regulation 23(9) of SEBI (LODR) Regulations, 2015 we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2019.13-06-2019